APO Research
Talk to an analyst

APO RESEARCH · REPORT

Lyme Disease Testing

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Lyme Disease Testing Market Analysis and Forecast 2026-2032

6 January 2026190 pages

Choose your research edition.

Industry ResearchLyme Disease Testing Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Lyme Disease Testing Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Lyme Disease Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Lyme Disease Testing Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Lyme Disease Testing Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Lyme Disease Testing market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Lyme Disease Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Lyme Disease Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Lyme Disease Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Lyme Disease Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Lyme Disease Testing include Quidel Corporation, Roche Holding AG, Fujirebio(H.U. Group Holdings), ZEUS Scientific, IGeneX, Thermo Fisher Scientific, Everlywell, Oxford Immunotec Global PLC(PerkinElmer) and BioMerieux, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Lyme Disease Testing, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Lyme Disease Testing, also provides the revenue of main regions and countries. Of the upcoming market potential for Lyme Disease Testing, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Lyme Disease Testing revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Lyme Disease Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Lyme Disease Testing revenue, projected growth trends, production technology, application and end-user industry.

Lyme Disease Testing Segment by Company

Quidel Corporation

Roche Holding AG

Fujirebio(H.U. Group Holdings)

ZEUS Scientific

IGeneX

Thermo Fisher Scientific

Everlywell

Oxford Immunotec Global PLC(PerkinElmer)

BioMerieux

Bio-Rad Laboratories

T2 Biosystems

Lyme Disease Testing Segment by Type

ELISA

Western Blotting

PCR

Others

Lyme Disease Testing Segment by Application

Hospital and Testing Agency

Personal

Lyme Disease Testing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lyme Disease Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Lyme Disease Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lyme Disease Testing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Lyme Disease Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Lyme Disease Testing company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Lyme Disease Testing revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Lyme Disease Testing Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. ELISA Major Player Table 3. Western Blotting Major Player Table 4. PCR Major Player Table 5. Others Major Player Table 6. Global Lyme Disease Testing Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Hospital and Testing Agency Major Player Table 8. Personal Major Player Table 9. Lyme Disease Testing Industry Trends Table 10. Lyme Disease Testing Industry Drivers Table 11. Lyme Disease Testing Industry Opportunities and Challenges Table 12. Lyme Disease Testing Industry Restraints Table 13. Global Lyme Disease Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Lyme Disease Testing Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Lyme Disease Testing Market Share by Region (2021-2026) Table 16. Global Lyme Disease Testing Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Lyme Disease Testing Market Share by Region (2027-2032) Table 18. Global Lyme Disease Testing Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Lyme Disease Testing Revenue Market Share by Players (2021-2026) Table 20. Global Lyme Disease Testing Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Lyme Disease Testing Key Players Headquarters & Area Served Table 22. Global Lyme Disease Testing Players, Product Type & Application Table 23. Global Lyme Disease Testing Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Lyme Disease Testing by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Lyme Disease Testing Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Lyme Disease Testing Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Lyme Disease Testing Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Lyme Disease Testing Revenue Market Share by Type (2021-2026) Table 30. Global Lyme Disease Testing Revenue Market Share by Type (2027-2032) Table 31. Global Lyme Disease Testing Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Lyme Disease Testing Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Lyme Disease Testing Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Lyme Disease Testing Revenue Market Share by Application (2021-2026) Table 35. Global Lyme Disease Testing Revenue Market Share by Application (2027-2032) Table 36. Quidel Corporation Company Information Table 37. Quidel Corporation Business Overview Table 38. Quidel Corporation Lyme Disease Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Quidel Corporation Lyme Disease Testing Product Portfolio Table 40. Quidel Corporation Recent Development Table 41. Roche Holding AG Company Information Table 42. Roche Holding AG Business Overview Table 43. Roche Holding AG Lyme Disease Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Roche Holding AG Lyme Disease Testing Product Portfolio Table 45. Roche Holding AG Recent Development Table 46. Fujirebio(H.U. Group Holdings) Company Information Table 47. Fujirebio(H.U. Group Holdings) Business Overview Table 48. Fujirebio(H.U. Group Holdings) Lyme Disease Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Fujirebio(H.U. Group Holdings) Lyme Disease Testing Product Portfolio Table 50. Fujirebio(H.U. Group Holdings) Recent Development Table 51. ZEUS Scientific Company Information Table 52. ZEUS Scientific Business Overview Table 53. ZEUS Scientific Lyme Disease Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. ZEUS Scientific Lyme Disease Testing Product Portfolio Table 55. ZEUS Scientific Recent Development Table 56. IGeneX Company Information Table 57. IGeneX Business Overview Table 58. IGeneX Lyme Disease Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. IGeneX Lyme Disease Testing Product Portfolio Table 60. IGeneX Recent Development Table 61. Thermo Fisher Scientific Company Information Table 62. Thermo Fisher Scientific Business Overview Table 63. Thermo Fisher Scientific Lyme Disease Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Thermo Fisher Scientific Lyme Disease Testing Product Portfolio Table 65. Thermo Fisher Scientific Recent Development Table 66. Everlywell Company Information Table 67. Everlywell Business Overview Table 68. Everlywell Lyme Disease Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Everlywell Lyme Disease Testing Product Portfolio Table 70. Everlywell Recent Development Table 71. Oxford Immunotec Global PLC(PerkinElmer) Company Information Table 72. Oxford Immunotec Global PLC(PerkinElmer) Business Overview Table 73. Oxford Immunotec Global PLC(PerkinElmer) Lyme Disease Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Oxford Immunotec Global PLC(PerkinElmer) Lyme Disease Testing Product Portfolio Table 75. Oxford Immunotec Global PLC(PerkinElmer) Recent Development Table 76. BioMerieux Company Information Table 77. BioMerieux Business Overview Table 78. BioMerieux Lyme Disease Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. BioMerieux Lyme Disease Testing Product Portfolio Table 80. BioMerieux Recent Development Table 81. Bio-Rad Laboratories Company Information Table 82. Bio-Rad Laboratories Business Overview Table 83. Bio-Rad Laboratories Lyme Disease Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Bio-Rad Laboratories Lyme Disease Testing Product Portfolio Table 85. Bio-Rad Laboratories Recent Development Table 86. T2 Biosystems Company Information Table 87. T2 Biosystems Business Overview Table 88. T2 Biosystems Lyme Disease Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 89. T2 Biosystems Lyme Disease Testing Product Portfolio Table 90. T2 Biosystems Recent Development Table 91. North America Lyme Disease Testing Revenue by Type (2021-2026) & (US$ Million) Table 92. North America Lyme Disease Testing Revenue by Type (2027-2032) & (US$ Million) Table 93. North America Lyme Disease Testing Revenue by Application (2021-2026) & (US$ Million) Table 94. North America Lyme Disease Testing Revenue by Application (2027-2032) & (US$ Million) Table 95. North America Lyme Disease Testing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 96. North America Lyme Disease Testing Revenue by Country (2021-2026) & (US$ Million) Table 97. North America Lyme Disease Testing Revenue by Country (US$ Million) & (2027-2032) Table 98. Europe Lyme Disease Testing Revenue by Type (2021-2026) & (US$ Million) Table 99. Europe Lyme Disease Testing Revenue by Type (2027-2032) & (US$ Million) Table 100. Europe Lyme Disease Testing Revenue by Application (2021-2026) & (US$ Million) Table 101. Europe Lyme Disease Testing Revenue by Application (2027-2032) & (US$ Million) Table 102. Europe Lyme Disease Testing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 103. Europe Lyme Disease Testing Revenue by Country (2021-2026) & (US$ Million) Table 104. Europe Lyme Disease Testing Revenue by Country (US$ Million) & (2027-2032) Table 105. China Lyme Disease Testing Revenue by Type (2021-2026) & (US$ Million) Table 106. China Lyme Disease Testing Revenue by Type (2027-2032) & (US$ Million) Table 107. China Lyme Disease Testing Revenue by Application (2021-2026) & (US$ Million) Table 108. China Lyme Disease Testing Revenue by Application (2027-2032) & (US$ Million) Table 109. Asia Lyme Disease Testing Revenue by Type (2021-2026) & (US$ Million) Table 110. Asia Lyme Disease Testing Revenue by Type (2027-2032) & (US$ Million) Table 111. Asia Lyme Disease Testing Revenue by Application (2021-2026) & (US$ Million) Table 112. Asia Lyme Disease Testing Revenue by Application (2027-2032) & (US$ Million) Table 113. Asia Lyme Disease Testing Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 114. Asia Lyme Disease Testing Revenue by Region (US$ Million) & (2021-2026) Table 115. Asia Lyme Disease Testing Revenue by Region (US$ Million) & (2027-2032) Table 116. SAMEA Lyme Disease Testing Revenue by Type (2021-2026) & (US$ Million) Table 117. SAMEA Lyme Disease Testing Revenue by Type (2027-2032) & (US$ Million) Table 118. SAMEA Lyme Disease Testing Revenue by Application (2021-2026) & (US$ Million) Table 119. SAMEA Lyme Disease Testing Revenue by Application (2027-2032) & (US$ Million) Table 120. SAMEA Lyme Disease Testing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 121. SAMEA Lyme Disease Testing Revenue by Country (2021-2026) & (US$ Million) Table 122. SAMEA Lyme Disease Testing Revenue by Country (US$ Million) & (2027-2032) Table 123. Research Programs/Design for This Report Table 124. Authors List of This Report Table 125. Secondary Sources Table 126. Primary Sources List of Figures Figure 1. Lyme Disease Testing Image Figure 2. Global Lyme Disease Testing Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Lyme Disease Testing Market Size Share 2021 VS 2025 VS 2032 Figure 4. ELISA Image Figure 5. Western Blotting Image Figure 6. PCR Image Figure 7. Others Image Figure 8. Global Lyme Disease Testing Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Lyme Disease Testing Market Size Share 2021 VS 2025 VS 2032 Figure 10. Hospital and Testing Agency Image Figure 11. Personal Image Figure 12. Global Lyme Disease Testing Market Size (US$ Million) & (2021-2032) Figure 13. Global Lyme Disease Testing Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Lyme Disease Testing Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Lyme Disease Testing Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Lyme Disease Testing Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Lyme Disease Testing Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Lyme Disease Testing Revenue Market Share by Type (2021-2032) Figure 20. Global Lyme Disease Testing Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Lyme Disease Testing Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Lyme Disease Testing Revenue Market Share by Application (2021-2032) Figure 23. North America Lyme Disease Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Lyme Disease Testing Revenue Share by Type (2021-2032) Figure 25. North America Lyme Disease Testing Revenue Share by Application (2021-2032) Figure 26. North America Lyme Disease Testing Revenue Share by Country (2021-2032) Figure 27. United States Lyme Disease Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Lyme Disease Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Lyme Disease Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Lyme Disease Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Lyme Disease Testing Revenue Share by Type (2021-2032) Figure 32. Europe Lyme Disease Testing Revenue Share by Application (2021-2032) Figure 33. Europe Lyme Disease Testing Revenue Share by Country (2021-2032) Figure 34. Germany Lyme Disease Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Lyme Disease Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Lyme Disease Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Lyme Disease Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Lyme Disease Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Lyme Disease Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Lyme Disease Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Lyme Disease Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Lyme Disease Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Lyme Disease Testing Revenue Share by Type (2021-2032) Figure 44. China Lyme Disease Testing Revenue Share by Application (2021-2032) Figure 45. Asia Lyme Disease Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Lyme Disease Testing Revenue Share by Type (2021-2032) Figure 47. Asia Lyme Disease Testing Revenue Share by Application (2021-2032) Figure 48. Asia Lyme Disease Testing Revenue Share by Region (2021-2032) Figure 49. Japan Lyme Disease Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Lyme Disease Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Lyme Disease Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Lyme Disease Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Lyme Disease Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Lyme Disease Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Lyme Disease Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Lyme Disease Testing Revenue Share by Type (2021-2032) Figure 57. SAMEA Lyme Disease Testing Revenue Share by Application (2021-2032) Figure 58. SAMEA Lyme Disease Testing Revenue Share by Country (2021-2032) Figure 59. Brazil Lyme Disease Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Lyme Disease Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Lyme Disease Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Lyme Disease Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Lyme Disease Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Lyme Disease Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Lyme Disease Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Lyme Disease Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Lyme Disease Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Lyme Disease Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Lyme Disease Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • ELISA
  • Western Blotting
  • PCR
  • Others
Applications
  • Hospital and Testing Agency
  • Personal
Companies covered
  • Quidel Corporation
  • Roche Holding AG
  • Fujirebio(H.U. Group Holdings)
  • ZEUS Scientific
  • IGeneX
  • Thermo Fisher Scientific
  • Everlywell
  • Oxford Immunotec Global PLC(PerkinElmer)
  • BioMerieux
  • Bio-Rad Laboratories
  • T2 Biosystems

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Lyme Disease Testing Market by Type
  3. 1.2.1 Global Lyme Disease Testing Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 ELISA
  5. 1.2.3 Western Blotting
  6. 1.2.4 PCR
  7. 1.2.5 Others
  8. 1.3 Lyme Disease Testing Market by Application
  9. 1.3.1 Global Lyme Disease Testing Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Hospital and Testing Agency
  11. 1.3.3 Personal
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Lyme Disease Testing Market Dynamics
  1. 2.1 Lyme Disease Testing Industry Trends
  2. 2.2 Lyme Disease Testing Industry Drivers
  3. 2.3 Lyme Disease Testing Industry Opportunities and Challenges
  4. 2.4 Lyme Disease Testing Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Lyme Disease Testing Market Perspective (2021-2032)
  2. 3.2 Global Lyme Disease Testing Growth Trends by Region
  3. 3.2.1 Global Lyme Disease Testing Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Lyme Disease Testing Market Size by Region (2021-2026)
  5. 3.2.3 Global Lyme Disease Testing Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Lyme Disease Testing Revenue by Players
  2. 4.1.1 Global Lyme Disease Testing Revenue by Players (2021-2026)
  3. 4.1.2 Global Lyme Disease Testing Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Lyme Disease Testing Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Lyme Disease Testing Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Lyme Disease Testing Key Players Headquarters & Area Served
  7. 4.4 Global Lyme Disease Testing Players, Product Type & Application
  8. 4.5 Global Lyme Disease Testing Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Lyme Disease Testing Market CR5 and HHI
  11. 4.6.3 2025 Lyme Disease Testing Tier 1, Tier 2, and Tier 3
5 Lyme Disease Testing Market Size by Type
  1. 5.1 Global Lyme Disease Testing Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Lyme Disease Testing Revenue by Type (2021-2032)
  3. 5.3 Global Lyme Disease Testing Revenue Market Share by Type (2021-2032)
6 Lyme Disease Testing Market Size by Application
  1. 6.1 Global Lyme Disease Testing Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Lyme Disease Testing Revenue by Application (2021-2032)
  3. 6.3 Global Lyme Disease Testing Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Quidel Corporation
  2. 7.1.1 Quidel Corporation Company Information
  3. 7.1.2 Quidel Corporation Business Overview
  4. 7.1.3 Quidel Corporation Lyme Disease Testing Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Quidel Corporation Lyme Disease Testing Product Portfolio
  6. 7.1.5 Quidel Corporation Recent Developments
  7. 7.2 Roche Holding AG
  8. 7.2.1 Roche Holding AG Company Information
  9. 7.2.2 Roche Holding AG Business Overview
  10. 7.2.3 Roche Holding AG Lyme Disease Testing Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Roche Holding AG Lyme Disease Testing Product Portfolio
  12. 7.2.5 Roche Holding AG Recent Developments
  13. 7.3 Fujirebio(H.U. Group Holdings)
  14. 7.3.1 Fujirebio(H.U. Group Holdings) Company Information
  15. 7.3.2 Fujirebio(H.U. Group Holdings) Business Overview
  16. 7.3.3 Fujirebio(H.U. Group Holdings) Lyme Disease Testing Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Fujirebio(H.U. Group Holdings) Lyme Disease Testing Product Portfolio
  18. 7.3.5 Fujirebio(H.U. Group Holdings) Recent Developments
  19. 7.4 ZEUS Scientific
  20. 7.4.1 ZEUS Scientific Company Information
  21. 7.4.2 ZEUS Scientific Business Overview
  22. 7.4.3 ZEUS Scientific Lyme Disease Testing Revenue and Gross Margin (2021-2026)
  23. 7.4.4 ZEUS Scientific Lyme Disease Testing Product Portfolio
  24. 7.4.5 ZEUS Scientific Recent Developments
  25. 7.5 IGeneX
  26. 7.5.1 IGeneX Company Information
  27. 7.5.2 IGeneX Business Overview
  28. 7.5.3 IGeneX Lyme Disease Testing Revenue and Gross Margin (2021-2026)
  29. 7.5.4 IGeneX Lyme Disease Testing Product Portfolio
  30. 7.5.5 IGeneX Recent Developments
  31. 7.6 Thermo Fisher Scientific
  32. 7.6.1 Thermo Fisher Scientific Company Information
  33. 7.6.2 Thermo Fisher Scientific Business Overview
  34. 7.6.3 Thermo Fisher Scientific Lyme Disease Testing Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Thermo Fisher Scientific Lyme Disease Testing Product Portfolio
  36. 7.6.5 Thermo Fisher Scientific Recent Developments
  37. 7.7 Everlywell
  38. 7.7.1 Everlywell Company Information
  39. 7.7.2 Everlywell Business Overview
  40. 7.7.3 Everlywell Lyme Disease Testing Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Everlywell Lyme Disease Testing Product Portfolio
  42. 7.7.5 Everlywell Recent Developments
  43. 7.8 Oxford Immunotec Global PLC(PerkinElmer)
  44. 7.8.1 Oxford Immunotec Global PLC(PerkinElmer) Company Information
  45. 7.8.2 Oxford Immunotec Global PLC(PerkinElmer) Business Overview
  46. 7.8.3 Oxford Immunotec Global PLC(PerkinElmer) Lyme Disease Testing Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Oxford Immunotec Global PLC(PerkinElmer) Lyme Disease Testing Product Portfolio
  48. 7.8.5 Oxford Immunotec Global PLC(PerkinElmer) Recent Developments
  49. 7.9 BioMerieux
  50. 7.9.1 BioMerieux Company Information
  51. 7.9.2 BioMerieux Business Overview
  52. 7.9.3 BioMerieux Lyme Disease Testing Revenue and Gross Margin (2021-2026)
  53. 7.9.4 BioMerieux Lyme Disease Testing Product Portfolio
  54. 7.9.5 BioMerieux Recent Developments
  55. 7.10 Bio-Rad Laboratories
  56. 7.10.1 Bio-Rad Laboratories Company Information
  57. 7.10.2 Bio-Rad Laboratories Business Overview
  58. 7.10.3 Bio-Rad Laboratories Lyme Disease Testing Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Bio-Rad Laboratories Lyme Disease Testing Product Portfolio
  60. 7.10.5 Bio-Rad Laboratories Recent Developments
  61. 7.11 T2 Biosystems
  62. 7.11.1 T2 Biosystems Company Information
  63. 7.11.2 T2 Biosystems Business Overview
  64. 7.11.3 T2 Biosystems Lyme Disease Testing Revenue and Gross Margin (2021-2026)
  65. 7.11.4 T2 Biosystems Lyme Disease Testing Product Portfolio
  66. 7.11.5 T2 Biosystems Recent Developments
8 North America
  1. 8.1 North America Lyme Disease Testing Revenue (2021-2032)
  2. 8.2 North America Lyme Disease Testing Revenue by Type (2021-2032)
  3. 8.2.1 North America Lyme Disease Testing Revenue by Type (2021-2026)
  4. 8.2.2 North America Lyme Disease Testing Revenue by Type (2027-2032)
  5. 8.3 North America Lyme Disease Testing Revenue Share by Type (2021-2032)
  6. 8.4 North America Lyme Disease Testing Revenue by Application (2021-2032)
  7. 8.4.1 North America Lyme Disease Testing Revenue by Application (2021-2026)
  8. 8.4.2 North America Lyme Disease Testing Revenue by Application (2027-2032)
  9. 8.5 North America Lyme Disease Testing Revenue Share by Application (2021-2032)
  10. 8.6 North America Lyme Disease Testing Revenue by Country
  11. 8.6.1 North America Lyme Disease Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Lyme Disease Testing Revenue by Country (2021-2026)
  13. 8.6.3 North America Lyme Disease Testing Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Lyme Disease Testing Revenue (2021-2032)
  2. 9.2 Europe Lyme Disease Testing Revenue by Type (2021-2032)
  3. 9.2.1 Europe Lyme Disease Testing Revenue by Type (2021-2026)
  4. 9.2.2 Europe Lyme Disease Testing Revenue by Type (2027-2032)
  5. 9.3 Europe Lyme Disease Testing Revenue Share by Type (2021-2032)
  6. 9.4 Europe Lyme Disease Testing Revenue by Application (2021-2032)
  7. 9.4.1 Europe Lyme Disease Testing Revenue by Application (2021-2026)
  8. 9.4.2 Europe Lyme Disease Testing Revenue by Application (2027-2032)
  9. 9.5 Europe Lyme Disease Testing Revenue Share by Application (2021-2032)
  10. 9.6 Europe Lyme Disease Testing Revenue by Country
  11. 9.6.1 Europe Lyme Disease Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Lyme Disease Testing Revenue by Country (2021-2026)
  13. 9.6.3 Europe Lyme Disease Testing Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Lyme Disease Testing Revenue (2021-2032)
  2. 10.2 China Lyme Disease Testing Revenue by Type (2021-2032)
  3. 10.2.1 China Lyme Disease Testing Revenue by Type (2021-2026)
  4. 10.2.2 China Lyme Disease Testing Revenue by Type (2027-2032)
  5. 10.3 China Lyme Disease Testing Revenue Share by Type (2021-2032)
  6. 10.4 China Lyme Disease Testing Revenue by Application (2021-2032)
  7. 10.4.1 China Lyme Disease Testing Revenue by Application (2021-2026)
  8. 10.4.2 China Lyme Disease Testing Revenue by Application (2027-2032)
  9. 10.5 China Lyme Disease Testing Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Lyme Disease Testing Revenue (2021-2032)
  2. 11.2 Asia Lyme Disease Testing Revenue by Type (2021-2032)
  3. 11.2.1 Asia Lyme Disease Testing Revenue by Type (2021-2026)
  4. 11.2.2 Asia Lyme Disease Testing Revenue by Type (2027-2032)
  5. 11.3 Asia Lyme Disease Testing Revenue Share by Type (2021-2032)
  6. 11.4 Asia Lyme Disease Testing Revenue by Application (2021-2032)
  7. 11.4.1 Asia Lyme Disease Testing Revenue by Application (2021-2026)
  8. 11.4.2 Asia Lyme Disease Testing Revenue by Application (2027-2032)
  9. 11.5 Asia Lyme Disease Testing Revenue Share by Application (2021-2032)
  10. 11.6 Asia Lyme Disease Testing Revenue by Country
  11. 11.6.1 Asia Lyme Disease Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Lyme Disease Testing Revenue by Country (2021-2026)
  13. 11.6.3 Asia Lyme Disease Testing Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Lyme Disease Testing Revenue (2021-2032)
  2. 12.2 SAMEA Lyme Disease Testing Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Lyme Disease Testing Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Lyme Disease Testing Revenue by Type (2027-2032)
  5. 12.3 SAMEA Lyme Disease Testing Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Lyme Disease Testing Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Lyme Disease Testing Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Lyme Disease Testing Revenue by Application (2027-2032)
  9. 12.5 SAMEA Lyme Disease Testing Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Lyme Disease Testing Revenue by Country
  11. 12.6.1 SAMEA Lyme Disease Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Lyme Disease Testing Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Lyme Disease Testing Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst